Switch to
View more

Brooks Laboratories Ltd

BROOKS
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹207 cr, stock is ranked 1,712
High RiskStock is 3.57x as volatile as Nifty
84.101.80 (+2.19%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹207 cr, stock is ranked 1,712
High RiskStock is 3.57x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
-12.84
PB RatioPB Ratio
2.62
Dividend YieldDiv. Yield
Sector PESector PE
38.16
Sector PBSector PB
4.82
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Brooks Laboratories Ltd. is a Contract Manufacturing Company. The Company manufacturers molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups.

Financial TrendFinancial statements 

201920202021202257.9170.1077.9991.99-14.80-24.37-19.36-16.18
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Newspaper Advertisements 
Announced OnAug 12, 2022

Brooks Laboratories Limited has informed the Exchange about Newspaper Advertisements of the financials for the 1st quarter ended 30th June 2022. | Download

Brooks Laboratories Limited has informed the Exchange about Newspaper Advertisements of the financials for the 1st quarter ended 30th June 2022. | Download

Disclosure of other UPSI/material event 
Announced OnAug 10, 2022

Brooks Laboratories Limited has informed the Exchange about Disclosure of other UPSI/material event | Download

Brooks Laboratories Limited has informed the Exchange about Disclosure of other UPSI/material event | Download

Outcome of Board Meeting 
Announced OnAug 10, 2022

Brooks Laboratories Limited has informed the Exchange about Board Meeting held on 10-Aug-2022 to consider financial statements for the period ended June 2022 | Download

Brooks Laboratories Limited has informed the Exchange about Board Meeting held on 10-Aug-2022 to consider financial statements for the period ended June 2022 | Download

See all events